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ABSTRACT Staphylococcal a-toxin is a 293-residue, sin-
gle-chain polypeptide that spontaneously assembles into a
heptameric pore in target cell membranes. To identify the
pore-forming domain, substitution mutants have been pro-
duced in which single cysteine residues were introduced
throughout the toxin molecule. By attaching the environmen-
tally sensitive dye acrylodan to the sulfhydryl groups, the
environment of individual amino acid side chains could be
probed. In liposomes, a single 23-amino acid sequence (resi-
dues 118–140) was found to move from a polar to a nonpolar
environment, indicating that this sequence forms the walls of
the pore. However, periodicity in side chain environmental
polarity could not be detected in the liposomal system. In the
present study, the f luorimetric analyses were extended to
physiological target cells. With susceptible cells such as rabbit
erythrocytes and human lymphocytes, the 23 central amino
acids 118–140 were again found to insert into the membrane;
in contrast to the previous study with liposomes, the expected
periodicity was now detected. Thus, every other residue in the
sequence 126–140 entered a nonpolar environment in a strik-
ing display of an amphipathic transmembrane b-barrel. In
contrast, human granulocytes were found to bind a-toxin to a
similar extent as lymphocytes, but the heptamers forming on
these cells failed to insert their pore-forming domain into the
membrane. As a consequence, nonfunctional heptamers as-
sembled and the cells remained viable. The data resolve the
molecular organization of a pore-forming toxin domain in
living cells and reveal that resistant cells can prevent insertion
of the functional domain into the bilayer.
Formation of transmembrane pores is a major mechanism by
which exogenous proteins damage target cells. Membrane
permeabilization underlies the action of many bacterioicins
(1), larval insecticidal toxins (2), microbial exotoxins (3), and
mammalian defense effector systems (4). Pore formation also
appears to be required for translocation of several intracellu-
larly acting toxins across lipid bilayers (5).
For a-toxin, a 293-residue single-chain polypeptide that is a
major virulence determinant of Staphylococcus aureus (6), the
following model for pore assembly accommodating four or-
ganizational and conformational states has emerged (6, 7).
The first state is the water-soluble, native monomer. The
second is the membrane-bound monomer. The third is the
heptameric pre-pore, where the pore-forming domain is on the
verge of membrane insertion. The final pore configuration
results after the functional domain enters the membrane,
forming the walls of a hydrophilic channel.
Substitution mutants were previously produced in which
single cysteine residues were introduced throughout the toxin
molecule (8). By attaching the polarity-sensitive dye acrylodan
(9) to the sulfhydryl groups, the environment of individual
amino acid side chains in toxin monomers and in membrane-
bound oligomers were probed. In liposomes, a single 23-amino
acid sequence (residues 118–140) was observed to move from
a polar to a nonpolar environment (8), and lipid insertion of
this amino acid sequence correlated with pore formation (10).
Fluorescence energy transfer data indicated that residue 130
was in immediate proximity with the cytoplasmic membrane
face (11). Other structure–function studies yielded data con-
sistent with the model of a cylindrical toxin pore formed by this
central molecular domain (12–15).
Heptameric a-toxin oligomers assemble spontaneously in
detergent solution (16, 17), and their three-dimensional struc-
ture has recently been resolved (18). On the assumption that
such oligomers are structurally identical to those formed in
lipid bilayers, these data show that the seven amphipathic
central domains encompassing amino acid residues 118–140
indeed form the walls of a water-filled channel in the form of
a b-barrel (18).
An essential complementary approach to the above studies
is the investigation of the molecular conformation of a-toxin
heptamers in membranes of physiological cell targets, and the
present investigation was undertaken to fill this information
gap. In the course of our experiments, it was found that human
granulocytes display a natural resistance against the pore-
forming action of a-toxin that is not due to hindrance of toxin
binding or heptamer assembly. Data from the fluorimetric
analyses are presented that demonstrate a striking difference
in the orientation of the pore-forming sequence in heptamers
assembled on toxin-susceptible versus toxin-resistant cells; this
difference correlated with and accounted for the cellular
phenotypes.
MATERIALS AND METHODS
Toxin Substitution Mutants. The production of 44 cysteine
substitution mutants has been described (8, 15, 19). Eight
additional mutants were produced, three at the N terminus
(19) and five completing the sequence 126–140 by PCR
mutagenesis according to published procedures (8, 20). The
latter mutants were as follows: I132C, G133C, L135C, I136C,
and N139C. All acrylodan-labeled mutants except N139C
retained full specific activity. Acrylodan-labeled N139C ex-
hibited an approximately 25% reduction in hemolytic activity,
but membrane-bound N139C assembled into heptamers to the
same extent as other toxin derivatives.The publication costs of this article were defrayed in part by page charge
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Cells. Human T-lymphocytes and neutrophil granulocytes
were prepared as described (21, 22). A total of 5 3 106 cellsyml
in PBS were incubated with a-toxin. Phagocytosis tests and
flow cytometry were performed as described (22).
Measurement of K1 Efflux and Intracellular ATP. For K1
efflux measurements, 107 cellsyml were incubated with a-toxin
at 37°C for 60 min. Samples were withdrawn and centrifuged
for 5 min at 250 3 g, followed by 5 min at 13,000 3 g. Potassium
concentrations were determined by an atomic absorption
spectrophotometer (type AA-5; Varian-Techtron, Melbourne,
Australia).
For measurements of cellular ATP, 105 cells in 200 ml of
medium were treated with a-toxin (60 min, 37°C) and then
lysed with 10 ml of 10% Triton X-100 (without centrifugation).
Each lysate was transferred into a vial containing 155 ml of
distilled water and 25 ml of luciferase (Boehringer Mannheim),
and chemiluminescence was measured in a luminometer (Bi-
oluminat LB 9500; Berthold, Wildbad, Germany). ATP con-
tents of toxin-treated cells were expressed as percent lumines-
cence relative to that of untreated cells (23).
Spectrof luorimetric Studies. Acrylodan-labeled toxins
were incubated with liposomes as described (8). Rabbit eryth-
rocytes (5 3 108 cellsyml) were lysed with 5 mgyml of labeled
toxin. T-lymphocytes or granulocytes (5 3 106 cellsyml) were
treated with 20 mgyml of labeled toxin for 45 min at 37°C.
Erythrocyte membranes were pelleted and washed in a bench
top microfuge (10,000 3 g for 5 min). Lymphocytes and
granulocytes were sedimented (2,000 3 g for 10 min), washed
twice, and resuspended in PBS. Fluorescence emission spectra
were recorded in a Spex Fluoromax fluorimeter (wavelength:
excitation 365 nm, emission 400–600 nm; scanning interval 1
nm; band passes: excitation 4 nm, emission 2 nm). For all
samples, the spectra of appropriate blanks (buffers, liposome,
or cell suspension) were recorded and subtracted from the
sample spectra (8). A narrow bore cuvette was used to
minimize spectral distortions due to light scattering.
RESULTS
Human Granulocytes Display a Primary Resistance Toward
the Pore-Forming Action of a-Toxin. In contrast to T-
lymphocytes, human granulocytes can be exposed to high
concentrations of a-toxin without becoming permeabilized.
No depletion of cellular K1 or ATP (Fig. 1) or inhibition of
phagocytic function (data not shown) was observed after
incubation of granulocytes with 20 mgyml a-toxin for 60 min.
The primary resistance of human granulocytes toward a-toxin
might be due to several different reasons. First, granulocytes
might lack toxin-binding sites. Second, oligomerization of
bound monomers might be inhibited. Third, heptamers might
form that are rapidly moved by endocytosis or shedding. Or
fourth, nonfunctional heptamers might assemble on these
membranes. The following experiments excluded the first
three possibilities.
Binding studies were performed using a radioiodinated
tracer, and it was found that binding of a-toxin occurred
rapidly (essentially complete within 1 min at 25°C) and to a
similar extent to both lymphocytes and granulocytes (data not
shown). In a second set of experiments, a cysteine-substitution
mutant S69C was employed. This toxin derivative could be
labeled with either fluorescein-maleimide or biotin-maleimide
without loss of pore-forming activity (24). When the fluores-
cein-labeled derivative was added to lymphocytes or granulo-
cytes, similar fluorescence intensities of the two cell types were
observed by flow cytometry (data not shown), indicating
similar binding of the toxin at the single-cell level. The S69C
mutant was then labeled with biotin-maleimide because this
enabled quantitative assessment of its cell surface localization
to be performed. Biotinylated S69C toxin was bound to cells,
and the surface accessibility of biotin was subsequently probed
by incubation of the cells with streptavidin-f luorescein. a-
Toxin could be detected on the cell surface over the entire
duration of the experiment (60 min) (Fig. 2). Use of labeled
S69C-toxin also enabled demonstration that no truncation of
the toxin within the heptamers had occurred. Thus, SDS-stable
oligomers were present on both lymphocytes and granulocytes,
and boiling generated a monomeric 34-kDa a-toxin (Fig. 3).
This finding was relevant because it rendered proteolytic
nicking as a mechanism for heptamer inactivation improbable.
Therefore, lack of permeabilization in granulocytes was due
neither to prevention of heptamer assembly nor to proteolytic
destruction of the toxin pore.
Molecular Architecture of a-Toxin Pore in Sensitive Cells.
The emission spectrum of acrylodan attached to single cysteine
residues distributed throughout the toxin molecule was ana-
lyzed in the monomeric toxin and in heptamers formed on
liposomes and cell membranes. A ‘‘blue’’ shift in emission
spectrum of the molecule following membrane-binding indi-
cated movement of acrylodan either into a hydrophobic pro-
tein pocket or into the lipid environment (8).
Fluorimetric data were obtained with 49 functionally intact,
acrylodan-labeled toxin mutants on erythrocyte membranes.
Fig. 4A shows the emission maxima for each derivative in
solution and in the membrane-bound heptamer. Acrylodan
attached to amino acid residues 118–140 displayed a marked
blue shift upon heptamer assembly. The fluorescence patterns
resembled those observed in liposomes (8) and were comple-
mented by data from mutants completing the series spanning
residues 126–140. There was one important difference: in
liposomes, no periodicity in side-chain environmental polarity
was discerned along the pore-forming sequence (8). With
erythrocyte membranes, the anticipated periodicity was found.
With liposomes and erythrocytes, similar blue shifts of all
even-numbered residues were observed that were partially
reversed upon delipidation with deoxycholate. Previous ex-
perimental data (8) indicated that this shift reversal reflected
contact of the labeled side chain with lipid in the bilayer. The
degree of fluorescent change varied depending on the deter-
FIG. 1. Measurement of cellular ATP-depletion and K1-eff lux in
a-toxin-treated cells. Lymphocytes (open symbols) or granulocytes
(filled symbols) were treated with a-toxin for 60 min at 37 C. K1
concentrations (squares) in supernatants were determined. Cells were
lysed with Triton X-100 and ATP concentrations in the lysates (circles)
were determined. Data represent means 6 SD (error bars) for three
independent experiments.
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gent used, due probably to detergent–lipid exchange. With the
odd residues, however, the emission maxima measured on cells
were always less shifted than on liposomes, approximating the
emission maxima of re-isolated heptamers (Fig. 4B). Partial
reversal of the blue shift was also observed with G122C and
V124C when heptamers were formed in and re-isolated from
erythrocytes; in the same system, shift reversal was not ob-
served with N121C. We were unable to produce mutants
N123C and T125C. From these data, a model for the organi-
zation of a-toxin on susceptible cells emerged in which only the
even residues in the pore-forming domain are in contact with
membrane lipids, whereas side chains of the odd residues face
toward the pore lumen.
Heptamers Formed on Resistant Cells Fail to Insert the
Pore-Forming Sequence into the Bilayer. The spectrofluori-
metric findings were very similar whether rabbit erythrocytes,
human lymphocytes, monocytes, or fibroblasts were employed.
With human granulocytes, however, a striking difference was
discovered exclusively within the pore-forming sequence.
Here, the blue shift in acrylodan fluorescence of those residues
exposed to the lipid environment on the other cell membranes
was absent (Fig. 4C). Apart from this difference, all the other
fluorimetric measurements yielded the same results as found
with sensitive cells. Thus, these data revealed that assembly of
toxin oligomers had occurred up to the final pre-pore stage
(see refs. 3 and 7 for schematic depictions), but granulocytes
can thwart the lethal membrane insertion step. As a conse-
quence, nonfunctional heptamers form on these cells.
DISCUSSION
The present data demonstrate how fluorescently labeled cys-
teine substitution mutants of a pore-forming toxin can be
utilized to obtain detailed information on the molecular
architecture of a membrane-spanning protein domain in phys-
iological cell targets. The rationale is straightforward: a blue
shift in fluorescence emission spectrum indicates movement of
a given amino acid side chain to a nonpolar environment. If the
blue shift is not reversed in delipidated oligomers, this indi-
cates burial of the reporter molecule within a protein pocket.
If, however, a partial shift reversal occurs upon delipidation,
this indicates immediate contact of the side chain with lipid (8).
It is notable that the degree of shift reversal is dependent on
the detergent used to replace the lipids (8), which is in accord
with the interpretation. The present investigation has gener-
ated a number of generally relevant insights. The observation
that employment of viable cells is feasible merits attention. Not
only does this imply that it is possible to analyze the confor-
mation of the functional domain in true biological targets, but
it will now become possible to follow the fate of the fluorescent
reporter molecule in cells over extended time periods. This
result will be of interest, for example, for the study of repair
processes that sometimes occur (25).
A major finding related to the difference in fluorimetric
measurements made exclusively within the pore-forming se-
quence on cells versus liposomes. In the latter, no periodicity
in environmental polarity could be detected, and this had
raised concerns about the reliability and resolution of the
method. In cell membranes, however, the anticipated period-
icity was found, and a model thus emerged in which every even
residue in the sequence 118–140 contacted lipid, whereas
every uneven residue did not. By exclusion, the latter must face
the lumen of the pore. Of note, the emission spectra of all
labeled residues facing the lumen were blue-shifted relative to
the monomers in solution. This finding probably reflected
protein–protein interactions within the channel because they
remained unchanged after detergent solubilization. The lack
of periodicity in side-chain environment previously observed
in artificial lipid bilayers could indicate that the b-strands enjoy
FIG. 2. Nonfunctional a-toxin molecules bound to granulocytes remain surface-exposed. Granulocytes (5 3 106 cellsyml) in PBS were incubated
with 20 mgyml of biotinylated S69C a-toxin (23) for 5 min at 37°C. Cells were then washed twice, suspended in buffer, and either incubated
immediately (B) or after 60 min (C) with streptavidin-f luorescein (5 mgyml) for 5 min at 37°C, and subjected to flow-cytometric analyses. Control
cells (A) incubated with unbiotinylated S69C a-toxin exhibited no fluorescence, whereas cells laden with biotinylated S69C a-toxin assumed a green
fluorescence that remained essentially unaltered after they had been incubated in buffer for 60 min (C). Horizontal axis: F1, relative green
fluorescence, vertical axis: F3, relative red fluorescence. Propidium iodide was added at 4 mgyml prior to flow cytometry, and lack of red
fluorescence indicated that cells remained impermeable to propidium iodide throughout the experiment.
FIG. 3. SDSyPAGE (UV-transilluminated) demonstrates that a-
toxin heptamers form on human lymphocytes (lanes 1 and 2) and
granulocytes (lanes 3 and 4). Cells were treated with 20 mgyml S69C
a-toxin labeled with fluorescein-maleimide (23) for 30 min at 37°C,
washed, and solubilized in SDS at 95°C to dissociate heptamers (lanes
1 and 3) or solubilized in SDS at room temperature to preserve
heptamers (lanes 2 and 4).
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FIG. 4. (A) Fluorescence emission max-
ima of acrylodan-labeled a-toxin cysteine
mutants in solution (e) and after heptamer
assembly on rabbit erythrocytes (h). An
emission blue shift indicates movement of
the fluorescence label to a more hydrophobic
environment. Significant blue shifts were
observed exclusively in the central region
spanning residues 118–140. (B) Emission
maxima of a-toxin cysteine mutants labeled
with acrylodan in the central pore-forming
domain. Emission spectra were recorded on
liposomes (), rabbit erythrocytes (e), and
heptamers re-isolated in deoxycholate (h).
(C) Emission maxima of acrylodan-labeled
a-toxin cysteine mutants measured on hu-
man granulocytes (h) and human T-
lymphocytes (e), showing lack of lipid con-
tact of the pore-forming domain in the toxin-
resistant granulocytes.
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greater rotational mobility in the membranes of small lipo-
somes that were employed in that study (8). It is indeed known
that the vesicle bilayer in small liposomes is strained, and
packing of the lipid molecules deviates from that given in large
vesicles (26, 27). Repetition of the experiments using large
unilamellar liposomes, prepared according to ref. 28, has in
fact recently generated data similar to those acquired with the
susceptible cells (data not shown).
Comparison of this model with the crystal structure of the
heptamer formed in detergent solution reveals superb con-
gruence (18). In the latter, residue 118 represents the starting
point from which the next 23 residues would enter the hydro-
phobic membrane interior, forming an amphipathic b-barrel,
with side-chains of even residues in contact with membrane
lipids, those of uneven residues facing the pore lumen, and
residue 129 forming the turning point at the cytoplasmic
membrane face. From previous data, we had indeed concluded
that residue 121 projects into the lumen of the channel and that
residue 130 resides near the cytoplasmic membrane face (8,
11). Surely, this congruence cannot be a mere coincidence, and
we conclude that the three-dimensional structure of the de-
tergent-assembled heptamer most likely is identical to the pore
formed on susceptible cells. On resistant cells such as human
granulocytes, however, the structure must clearly be different.
The present data revealing lack of membrane insertion of the
pore-forming domain show the molecular mechanism of cel-
lular resistance to a pore-forming toxin and highlight the
usefulness of the fluorimetric approach for the study of
molecular toxin organization in cell membranes. The method
compares favorably with electron spin resonance measure-
ments using cysteine substitution mutants which have recently
permitted the transmembrane orientation of the putative
pore-forming a-helix of diphtheria toxin B subunit to be
mapped in liposomes (29), and the fluorimetric approach is
technically certainly less demanding. The reasons underlying
lack of insertion of the stem domain in granulocytes remains
to be elucidated. Ongoing experiments indicate that lack of
insertion correlates with nonfunctional heptameric pre-pore
assembly in several other cases (unpublished data).
Inhibition of membrane insertion may be a mechanism
underlying resistance of cells toward other pore-forming pro-
teins. Streptolysin-O occasionally can assemble into nonfunc-
tional polymers (30), and homologous restriction factors in-
hibit complement (31), in part also by causing formation of
nonlytic terminal complexes (32). Moreover, membrane le-
sions can sometimes be repaired (25, 31). Environmental
probing with fluorescent cysteine-substitution mutants is a
potentially useful tool which may yield clues on the responsible
mechanisms.
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